| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.004 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |